Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin

J Clin Microbiol. 2008 Jul;46(7):2471; author reply 2471-2. doi: 10.1128/JCM.00519-08.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Daptomycin / pharmacology
  • Daptomycin / therapeutic use*
  • Drug Resistance, Bacterial*
  • Endocarditis, Bacterial / drug therapy*
  • Endocarditis, Bacterial / microbiology
  • Humans
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Daptomycin